Skip to content

Author

Liang Song

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Bevacizumab in first-line postoperative treatment of advanced ovarian cancer: from high-risk stratification to precision decision-making

Bevacizumab is an important component of first-line therapy for advanced epithelial ovarian cancer; however, the precise identification of patients who will benefit and how to optimize its use in the era of poly (ADP-ribose) polymerase inhibitors (PARPi) remains a core challenge in clinical practice. This review system...

Lan Zhong, Liang Song · 0 citations
Review Open access Oct 2026

Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation

Ovarian, endometrial, and cervical cancers represent major threats to women’s health worldwide. The profound heterogeneity of their immune microenvironments has rendered immune checkpoint blockade (ICB) therapies, particularly PD-1/PD-L1 inhibitors, far less effective than anticipated in gynecological malignancies. Con...

Dong-Mei Li, Kai-Ge Pei, Bo-Wen Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.